Single-chain antibody variable region-targeted interleukin-2 stimulates T cell killing of human colorectal carcinoma cells.
Recombinant DNA techniques were used to clone, construct and express the bifunctional molecule FV/IL-2. The FV/IL-2 is a single-chain 37 kDa fusion protein expressed in Escherichia coli under control of the strong T7 bacteriophage promoter in the expression vector pT7-7-FV-IL-2. The fused gene fragment FV-IL-2 contains a single-chain anti-TAG72 FV gene fragment and the human recombinant cDNA fragment of the IL-2 molecule. The renatured soluble form of FV/IL-2 was purified from E. coli inclusion bodies using hydroxylapatite chromatography. The yield of this fusion protein was estimated at 2.0 mg/L. Our data showed that the FV/IL-2 molecule retained the TAG72 antigen-binding specificity and the IL-2 activity as measured in the standard T cell proliferation as well as cytotoxicity assays. Therefore, it may prove to be useful in targeting the biological effect of IL-2 to tumour cells and stimulating its immune destruction.[1]References
- Single-chain antibody variable region-targeted interleukin-2 stimulates T cell killing of human colorectal carcinoma cells. Xiang, J., Liu, E., Moyana, T., Qi, Y. Immunol. Cell Biol. (1994) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
